Skip to main content
    T

    The Clorox Company (CLX)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $106.67
    -3.50 (-3.18%)

    Market Cap: $13.35B

    Last updated: Nov 17, 2026 at 4:42 PM ET

    The Clorox Company (CLX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    The Clorox Company (CLX) has a market cap of $13.35B and an enterprise value of $18.32B. Its dividend yield is 4.69%. Its trailing P/E of 17.1x is below its 10-year median of 24.5x.

    Total Valuation

    Enterprise value is 37.27% above the market cap, as debt exceeds cash.

    Market Cap$13.35B
    Enterprise Value$18.32B
    Latest price (Nov 17, 2026)$106.67

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 28, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Last Ex-Dividend DateOct 28, 2026
    Last Payment DateNov 13, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count shrank 0.64% a year over 3 years.

    Shares Outstanding121.62M
    Shares Change (YoY)-0.82%
    Share Count Growth (3Y CAGR)-0.64%

    Valuation Ratios

    The price to sales ratio is 1.8x. Its year-end P/E ranged from 15.4x to 39.3x from 2016 to 2025.

    P/E Ratio17.1x
    Forward P/E18.4x
    P/S Ratio1.8x
    Forward P/S1.7x
    P/FCF Ratio28.6x
    P/OCF Ratio20.2x
    PEG Ratio1.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 13.9x EBITDA and 39.6x free cash flow.

    EV / Earnings26.5x
    EV / Sales2.5x
    EV / EBITDA13.9x
    EV / EBIT17.4x
    EV / FCF39.6x

    Price Statistics

    The stock is up 4.05% over 52 weeks and trades 20.44% above its 50-day average.

    Beta (1Y)0.37
    52-Week Change+4.05%
    1-Month Change+26.46%
    3-Month Change+0.28%
    6-Month Change+16.59%
    5-Year Change-46.02%
    10-Year Change-26.68%
    Total Return (1Y)+8.91%
    Total Return (3Y CAGR)-6.34%
    Total Return (5Y CAGR)-5.97%
    Return vs SPY (1Y)-3.83%
    Max Drawdown (1Y)-36.86%
    Max Drawdown (3Y)-51.54%
    Sharpe Ratio (1Y)0.23
    Correlation with SPY (1Y)0.16
    50-Day Average$88.57
    200-Day Average$97.67
    52-Week Range$77.99 to $124.03
    RSI (14 Days)72.1
    Average Volume (20 Days)3.69M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.65x current liabilities.

    Current Ratio0.65x
    Quick Ratio0.39x
    Debt / EBITDA4.01x
    Debt / FCF11.39x
    Interest Coverage6.60x

    Returns and Efficiency

    Return on invested capital is 15.93% over the last 12 months, against a 5-year average of 16.61%.

    Return on Assets (ROA)8.84%
    Return on Invested Capital (ROIC)15.93%
    Return on Capital Employed (ROCE)21.53%
    ROE (5Y Average)234.28%
    ROA (5Y Average)7.59%
    ROIC (5Y Average)16.61%
    Asset Turnover1.08x
    Inventory Turnover5.39x
    Receivables Turnover9.37x
    Cash Conversion Cycle-37 days

    Taxes

    Income tax took 22.33% of pretax income over the last 12 months.

    Income Tax (TTM)$199.00M
    Effective Tax Rate22.33%

    Scores

    CLX has an Altman Z-Score of 2.26, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.26
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $7.20B over the last 12 months is up 6.28% from the 12 months before.

    Revenue$7.20B
    Revenue Growth (YoY)+6.28%
    Gross Profit$3.02B
    Operating Income$1.05B
    Pretax Income$891.00M
    Net Income$692.00M
    EBITDA$1.29B
    EBIT$1.05B
    Reported EPS (TTM)$6.24

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$184.00M
    Total Debt$5.16B
    Net Debt$4.97B
    Net Debt Per Share$40.90
    Working Capital-$1.02B
    Shareholder Equity-$39.00M
    Tangible Book Value-$3.56B
    Total Assets$7.83B
    Total Liabilities$7.71B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $209.00M of capital spending, operating cash flow left $453.00M of free cash flow.

    Operating Cash Flow$662.00M
    Capital Expenditures$209.00M
    Free Cash Flow$453.00M
    FCF Per Share$3.75
    Depreciation and Amortization$237.00M
    Dividends Paid$618.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 14.58%, against a 5-year average of 10.90%.

    Gross Margin41.94%
    Operating Margin14.58%
    Pretax Margin12.38%
    Net Margin9.62%
    EBITDA Margin17.88%
    EBIT Margin14.59%
    FCF Margin6.30%
    Gross Margin (5Y Average)41.14%
    Operating Margin (5Y Average)10.90%
    Net Margin (5Y Average)6.69%

    Growth

    Revenue fell 3.11% a year over 3 years, and EPS grew 2.86% a year.

    Revenue Growth (3Y CAGR)-3.11%
    Revenue Growth (5Y CAGR)-1.75%
    EPS Growth (3Y CAGR)+2.86%
    EPS Growth (5Y CAGR)-6.66%
    FCF Growth (3Y CAGR)-24.20%
    FCF Growth (5Y CAGR)-15.59%
    Operating Income Growth (3Y CAGR)+30.80%

    Revenue and profit by year

    Dividends and Yields

    CLX pays out 87.52% of earnings as dividends.

    Dividend Per Share (Annual)$5.00
    Dividend Yield4.69%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+1.68%
    Dividend Growth (5Y CAGR)+2.54%
    Payout Ratio87.52%
    FCF Payout Ratio136.42%
    Earnings Yield5.85%
    FCF Yield3.49%
    Buyback Yield1.26%
    Shareholder Yield6.02%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Aug 24, 1999.

    Last Split DateAug 24, 1999
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, CLX has the 9th highest P/E and the 7th highest P/S.

    P/E Ratio17.1x vs 24.9x median
    P/S Ratio1.8x vs 2.2x median
    ROIC15.93% vs 15.02% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.28% vs +3.05% median
    Dividend Yield4.69% vs 1.22% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.79% and EPS growth at 5.52% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.79%
    EPS Growth Forecast (2Y CAGR)+5.52%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLX

    What is CLX's market cap?

    The Clorox Company has a market cap of $13.35B. Its enterprise value, which adds debt and subtracts cash, is $18.32B.

    What is CLX's P/E ratio?

    The Clorox Company has a trailing P/E ratio of 17.1x and a forward P/E of 18.4x.

    How many shares of CLX are outstanding?

    The Clorox Company has 121.62M shares outstanding. The count is down 0.82% from a year earlier.

    Does CLX pay a dividend?

    Yes. The Clorox Company pays $5.00 a share a year, a dividend yield of 4.69%.

    How much debt does CLX have?

    The Clorox Company has $5.16B of total debt and $184.00M of cash and equivalents, a net debt position of $4.97B.